Heterogeneous topographic profiles of kinetic and cell cycle regulator microsatellites in atypical (dysplastic) melanocytic nevi

Modern Pathology

Volumn 24, Issue 4, 2011, Pages 471-486

  Husain, Ehab A ^a   Mein, Charles ^a   Pozo, Lucia ^b   Blanes, Alfredo ^c   Diaz Cano, Salvador J ^c,d  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MÁLAGA   (Spain)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

atypical melanocytic nevus; cell cycle regulator; kinetics; microsatellite; progression; topographic heterogeneity

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; KI 67 ANTIGEN; MICROSATELLITE DNA; PROTEIN P53;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; ATYPICAL MELANOCYTIC NEVUS; CANCER GRADING; CANCER GROWTH; CELL CYCLE REGULATION; CELL KINETICS; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; DERMIS; DNA FRAGMENTATION; FEMALE; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MELANOCYTIC NEVUS; MELANOMA; MICRODISSECTION; NICK END LABELING; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TOPOGRAPHY;

ADULT; APOPTOSIS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KINETICS; LONDON; MALE; MICRODISSECTION; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; NEVUS, PIGMENTED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SPAIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79953330774     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.143     Document Type: Article

References (50)

1. Diaz-Cano SJ. General morphological and biological features of neoplasms: integration of molecular findings. Histopathology 2008;53:1-19. (Pubitemid 351861972)
2. Clark Jr WH, Elder DE, Guerry Dt, et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984;15:1147-1165. (Pubitemid 15128121)
3. Elder D. Tumor progression, early diagnosis and prognosis of melanoma. Acta Oncol 1999;38:535-547. (Pubitemid 29333733)
4. Elder DE, Clark Jr WH, Elenitsas R, et al. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol 1993; 10:18-35. (Pubitemid 23125014)
5. Pozo L, Naase M, Cerio R, et al. Critical analysis of histologic criteria for grading atypical (dysplastic) melanocytic nevi. Am J Clin Pathol 2001;115: 194-204. (Pubitemid 32150677)
6. Pozo-Garcia L, Diaz-Cano SJ. Clonal origin and expansions in neoplasms: biologic and technical aspects must be considered together. Am J Pathol 2003;162: 353-354.
7. Diaz-Cano SJ, Blanes A, Wolfe HJ. PCR techniques for clonality assays. Diagn Mol Pathol 2001;10:24-33. (Pubitemid 32180180)
8. Salomon RN, Diaz-Cano S. Introduction to apoptosis. Diagn Mol Pathol 1995;4:235-238.
9. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-28.
10. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994;73:2013-2026. (Pubitemid 24107952)
11. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
12. Schulte-Hermann R, Grasl-Kraupp B, BurschW. Tumor development and apoptosis. Int Arch Allergy Immunol 1994;105:363-367. (Pubitemid 24365647)
13. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 1995;147:545-560.
14. Haas-Kogan DA, Kogan SC, Levi D, et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995;14:461-472.
15. Knudson Jr AG. Hereditary cancers: from discovery to intervention. J Natl Cancer Inst Monogr 1995;17:5-7.
16. Knudson Jr AG. Mutation and cancer: a personal odyssey. Adv Cancer Res 1995;67:1-23.
17. Diaz-Cano SJ, de Miguel M, Blanes A, et al. Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia. J Clin Endocrinol Metab 2001;86:3948-3957. (Pubitemid 32756002)
18. Diaz-Cano SJ. Designing a molecular analysis of clonality in tumours. J Pathol 2000;191:343-344. (Pubitemid 30649901)
19. Blanes A, Diaz-Cano SJ. Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas. World J Gastroenterol 2006;12:5932-5940. (Pubitemid 44608470)
20. Blanes A, Sanchez-Carrillo JJ, Diaz-Cano SJ. Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair. J Clin Endocrinol Metab 2006;91:1150-1158. (Pubitemid 43357794)
21. Baithun SI, Naase M, Blanes A, et al. Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications. Virchows Arch 2001;438:289-297. (Pubitemid 32247170)
22. Blanes A, Diaz-Cano SJ. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions. Hum Pathol 2006;37:1295-1303. (Pubitemid 44380274)
23. Diaz-Cano SJ, Blanes A, Rubio J, et al. Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. Lab Invest 2000; 80:279-289. (Pubitemid 30167788)
24. Blanes A, Rubio J, Martinez A, et al. Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes. Am J Clin Pathol 2002;118:93-100. (Pubitemid 34734258)
25. Diaz-Cano SJ. Are PCR artifacts in microdissected samples preventable? Hum Pathol 2001;32:1415-1416. (Pubitemid 34038681)
26. Diaz-Cano SJ, Brady SP. DNA extraction from formalinfixed, paraffin-embedded tissues: protein digestion as a limiting step for retrieval of high-quality DNA. Diagn Mol Pathol 1997;6:342-346. (Pubitemid 28175934)
27. Diaz-Cano SJ, de Miguel M, Blanes A, et al. Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates. J Pathol 2000;192:221-228.
28. Diaz-Cano SJ, de Miguel M, Blanes A, et al. Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex. Am J Pathol 2000;156:311-319. (Pubitemid 30644465)
29. Rubio J, Blanes A, Sanchez-Carrillo JJ, et al. Microsatellite abnormalities and somatic down-regulation of mismatch repair characterize nodular-trabecular muscle-invasive urothelial carcinoma of the bladder. Histopathology 2007;51:458-467. (Pubitemid 47437827)
30. Diaz-Cano SJ. Kinetic topographical heterogeneity in follicular thyroid neoplasms and growth patterns. Histopathology 2007;51:416-418. (Pubitemid 47301616)
31. Diaz-Cano SJ, Garcia-Moliner M, Carney W, et al. Bcl-2 expression and DNA fragmentation in breast carcinoma, pathologic and steroid hormone receptors correlates. Diagn Mol Pathol 1997;6:199-208. (Pubitemid 28047557)
32. Koch M, de Miguel M, Hofler H, et al. Kinetic profiles of intraepithelial and invasive prostatic neoplasias: the key role of down-regulated apoptosis in tumor progression. Virchows Arch 2000;436:413-420. (Pubitemid 30312156)
33. Harjacek M, Diaz-Cano S, De Miguel M, et al. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis. J Rheumatol 2001;28: 1914-1922. (Pubitemid 32726944)
34. Clemente C, Cochran AJ, Elder DE, et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol 1991;22: 313-319.
35. Barnhill RL, Roush GC, Duray PH. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol 1990;21:51-58. (Pubitemid 20042405)
36. Takata M, Saida T. Early cancers of the skin: clinical, histopathological, and molecular characteristics. Int J Clin Oncol 2005;10:391-397. (Pubitemid 41821522)
37. Wang Y, Rao U, Mascari R, et al. Molecular analysis of melanoma precursor lesions. Cell Growth Differ 1996; 7:1733-1740. (Pubitemid 26415170)
38. Arumi-Uria M, McNutt NS, Finnerty B. Grading of atypia in nevi: correlation with melanoma risk. Mod Pathol 2003;16:764-771. (Pubitemid 37011071)
39. Shors AR, Kim S, White E, et al. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol 2006;155:988-993. (Pubitemid 44564509)
40. Duncan LM, Berwick M, Bruijn JA, et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol 1993;100:318S-321S. (Pubitemid 23083187)
41. Gimotty PA, Guerry D, Ming ME, et al. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol 2004; 22:3668-3676. (Pubitemid 41095205)
42. Gimotty PA, Van Belle P, Elder DE, et al. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. J Clin Oncol 2005;23:8048-8056. (Pubitemid 46657407)
43. Pozo L, Diaz-Cano SJ. Tumor screening and biology in malignant melanomas. Arch Dermatol 2000;136: 934-935. (Pubitemid 30604298)
44. Diaz-Cano SJ. Molecular mechanisms in melanoma. N Engl J Med 2006;355:1395.
45. Pozo L, Husein E, Blanes A, et al. The correlation of regression with the grade of dysplasia (atypia) in melanocytic naevi. Histopathology 2008;52:387-389. (Pubitemid 351208051)
46. Arif S, Patel J, Blanes A, et al. Cytoarchitectural and kinetic features in the histological evaluation of follicular thyroid neoplasms. Histopathology 2007;50: 750-763. (Pubitemid 46683933)
47. Alonso SR, Ortiz P, Pollan M, et al. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am J Pathol 2004;164:193-203. (Pubitemid 38364604)
48. Bhatt KV, Hu R, Spofford LS, et al. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinaseassociated protein 2-mediated degradation of p27Kip1 in human melanoma cells. Oncogene 2007;26: 1056-1066.
49. Denicourt C, Saenz CC, Datnow B, et al. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res 2007;67: 9238-9243. (Pubitemid 47535911)
50. Zhang H, Schneider J, Rosdahl I. Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells. Int J Oncol 2002;21: 43-48.